Market Research Logo

Human Milk Oligosaccharides (HMO) Market Analysis By Application (Infant Formula, Functional Food & Beverages, Food Supplements) And Segment Forecasts To 2024

Human Milk Oligosaccharides (HMO) Market Analysis By Application (Infant Formula, Functional Food & Beverages, Food Supplements) And Segment Forecasts To 2024

The global human milk oligosaccharides market is expected to reach USD 170.4 million by 2024, according to a new report by Grand View Research, Inc. Increasing application scope in functional beverages and infant formula is expected to have a positive impact on growth.

Lack of protective enzymes in general infant formula and in breastfed milk, leading to high infant mortality rate, is likely to augment human milk oligosaccharides market growth. In 1990, the mortality rate of infants was 63 deaths per 1,000 live births, and in 2015, the rate declined to only 32 deaths per 1,000 live births.

Growth of functional food & beverage industry in China, Brazil, India, Poland, South Korea, and Mexico is also likely to propel growth over the forecast period. Rising disposable income and increasing concerns of middle class population towards health issues in emerging economies such as India and China are also expected to be key factors contributing to market growth for dietary supplements over the next six years.

Further key findings from the report suggest:

Demand for human milk oligosaccharides in infant formula is likely to witness growth of over 12% over the forecast period.Growing utilization of nutritional products particularly in Asia Pacific and North African countries is likely to propel demand.

Functional food & beverages accounted for over 15% of the global volume share in 2015. The functional food industry is highly dominated by dairy products. There is high demand for functional food & beverages with prebiotic properties. Human milk oligosaccharides not only provide prebiotic effects but also stimulate neurological health of human beings. These properties of human milk oligosaccharides are expected to drive growth in functional food & beverages over the next eight years.

Europe was the largest market for human milk oligosaccharides in 2015 on account of increasing utilization of LNnT & 2’FL in infant formulations. In addition, rising demand for functional food products including milk formula, energy drinks, and yogurt in Europe is likely to fuel demand for human milk oligosaccharides in the region.

The global human milk oligosaccharides market is consolidated on account of presence of limited number of players occupying major share. Many manufacturers are involved in extensive R&D for development of low cost technologies for production of HMO in large scale. 2’FL, 3’FL, 3’SL, and 6’SL are some of the majorly produced HMOs.

For the purpose of this report, Grand View Research has segmented the global human milk oligosaccharides market on the basis of application and region:

In July 2015, Inbiose NV along with other companies initiated CARBOSURF project under Bio-Based Industries Joint Undertaking (BBI JU) in order to device new fermentation process to derive glycolipid biosurfactants and sialylated carbohydrates. In October 2014, Madolac Laboratories announced completion of second phase of its HMO purification plant. This plant would synthesize HMOs in large scale, which would be further used in scientific research and clinical trials.


Chapter 1 Research Methodology
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 HMO Industry Outlook
3.1 HMO market segmentation
3.2 HMO market size and growth prospects, 2013 - 2024
3.3 HMO - Value chain analysis
3.3.1 Vendor landscape
3.4 Raw material outlook
3.5 Technology overview
3.6 Regulatory framework
3.6.1 European Commission: Regulation (EC) No 258/97 of the European Parliament
3.7 HMO market dynamics
3.7.1 Market driver analysis
3.7.1.1 Positive dairy industry outlook
3.7.1.2 Growing dietary supplements market
3.7.1.3 Rising concerns towards gut health
3.7.2 Market restraints analysis
3.7.2.1 Lack of technology for large-scale production
3.7.2.2 High R&D cost
3.8 Key opportunities prioritized
3.9 HMO competitive landscape
3.10 HMO Porter’s analysis
3.11 HMO market PESTEL analysis
3.12 Pricing trends 2013 - 2024
Chapter 4 HMO Product Outlook
4.1 2’-Fucosyllactose (2’FL)
4.1.1 : Specifications
4.1.2 : Key Suppliers
4.1.3 : Applications
4.1.4 : Patents
4.1.5 : Production Routes
4.1.6 : Manufacturers
4.2 3’-Fucosyllactose (3’FL)
4.2.1 : Specifications
4.2.2 : Key Suppliers
4.2.3 : Applications
4.2.4 : Patents
4.2.5 :Production Routes
4.2.6 : Manufacturers
4.3 3’-Sialyllactose (3’SL)
4.3.1 : Specifications
4.3.2 : Key Suppliers
4.3.3 : Applications
4.3.4 : Patents
4.3.5 : Production Routes
4.3.6 : Manufacturers
4.4 6’-Sialyllactose (6’SL)
4.4.1 : Specifications
4.4.2 : Key Suppliers
4.4.3 : Applications
4.4.4 : Patents
4.4.5 : Production Routes
4.4.6 : Manufacturers
4.5 Lacto-N-tetraose (LNT)
4.5.1 : Specifications
4.5.2 : Key Suppliers
4.5.3 : Patents
4.5.4 : Applications
4.5.5 : Production Routes
4.5.6 : Manufacturers
4.6 Lacto-N-neotetraose (LNnT)
4.6.1 : Specifications
4.6.2 : Key Suppliers
4.6.3 : Patents
4.6.4 : Applications
4.6.5 : Production Routes
4.6.6 : Manufacturers
Chapter 5 HMO Application Outlook
5.1 Global HMO market volume share by application, 2015 & 2024
5.2 Infant Formula
5.2.1 Global HMO market estimates and forecast in infant formula, 2013 - 2024 (Grams) (USD 000)
5.2.2 Global HMO market estimates and forecast in infant formula, by region, 2013 - 2024 (Grams) (USD 000)
5.3 Functional Food & Beverages
5.3.1 Global HMO market estimates and forecast in functional food & beverages, 2013 - 2024 (Grams) (USD 000)
5.3.2 Global HMO market estimates and forecast in functional food & beverages, by region, 2013 - 2024 (Grams) (USD 000)
5.4 Food Supplements
5.4.1 Global HMO market estimates and forecast in food supplements, 2013 - 2024 (Grams) (USD 000)
5.4.2 Global HMO market estimates and forecast in food supplements, by region, 2013 - 2024 (Grams) (USD 000)
5.5 Others
5.5.1 Global HMO market estimates and forecast in other applications, 2013 - 2024 (Grams) (USD 000)
5.5.2 Global HMO market estimates and forecast in other applications, by region, 2013 - 2024 (Grams) (USD 000)
Chapter 6 HMO Regional Outlook
6.1 Global HMO market volume share by region, 2015 & 2024
6.2 North America
6.2.1 North America HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.2.2 North America HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.2.3 U.S.
6.2.3.1 U.S. HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.2.3.2 U.S. HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.3 Europe
6.3.1 Europe HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.3.2 Europe HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.3.3 UK
6.3.3.1 UK HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.3.3.2 UK HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.3.4 Germany
6.3.4.1 Germany HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.3.4.2 Germany HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.4 Asia Pacific
6.4.1 Asia Pacific HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.4.2 Asia Pacific HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.4.3 China
6.4.3.1 China HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.4.3.2 China HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.4.4 Japan
6.4.4.1 Japan HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.4.4.2 Japan HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.5 Latin America
6.5.1 Latin America HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.5.2 Latin America HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.5.3 Brazil
6.5.3.1 Brazil HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.5.3.2 Brazil HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
6.6 MEA
6.6.1 MEA HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
6.6.2 MEA HMO market estimates and forecast, by application, 2013 - 2024 (Grams) (USD 000)
Chapter 7 Competitive Landscape
7.1 Inbiose NV
7.1.1 Company Overview
7.1.2 Financial Performance
7.1.3 Product Benchmarking
7.1.4 Strategic Initiatives
7.2 Elicityl S.A.
7.2.1 Company Overview
7.2.2 Financial Performance
7.2.3 Product Benchmarking
7.2.4 Strategic Initiatives
7.3 Jennewein Biotechnologie GmbH
7.3.1 Company Overview
7.3.2 Financial Performance
7.3.3 Product Benchmarking
7.3.4 Strategic Initiatives
7.4 Glycom A/S
7.4.1 Company Overview
7.4.2 Financial Performance
7.4.3 Product Benchmarking
7.5 Medolac Laboratories
7.5.1 Company Overview
7.5.2 Financial Performance
7.5.3 Product Benchmarking
7.5.4 Strategic Initiatives
7.6 ZuChem Inc.
7.6.1 Company Overview
7.6.2 Financial Performance
7.6.3 Product Benchmarking
7.6.4 Strategic Initiatives
7.7 Glycosyn LLC
7.7.1 Company Overview
7.7.2 Financial Performance
7.7.3 Product Benchmarking
List of Tables
1. HMO - Industry Summary & Key Buying Criteria
2. Global HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
3. Global HMO market volume, by region, 2013 - 2024 (Grams)
4. Global HMO market revenue, by region, 2013 - 2024 (USD 000)
5. Global HMO market volume, by application, 2013 - 2024 (Grams)
6. Global HMO market revenue, by application, 2013 - 2024 (USD 000)
7. Vendor landscape
8. HMO - Key market driver analysis
9. HMO - Key market restraint analysis
10. 2’FL Specifications
11. 3’FL Specifications
12. 3’SL Specifications
13. 6’SL Specifications
14. LNT Specifications
15. LNnT Specifications
16. Global HMO market estimates and forecast in infant formula, 2013 - 2024 (Grams) (USD 000)
17. Global HMO market estimates and forecast in infant formula, by region, 2013 - 2024 (Grams)
18. Global HMO market estimates and forecast in infant formula, by region, 2013 - 2024 (USD 000)
19. Global HMO market estimates and forecast in functional food & beverages, 2013 - 2024 (Grams) (USD 000)
20. Global HMO market estimates and forecast in functional food & beverages, by region, 2013 - 2024 (Grams)
21. Global HMO market estimates and forecast in functional food & beverages, by region, 2013 - 2024 (USD 000)
22. Global HMO market estimates and forecast in food supplements, 2013 - 2024 (Grams) (USD 000)
23. Global HMO market estimates and forecast in food supplements, by region, 2013 - 2024 (Grams)
24. GlobalHMO market estimates and forecast in food supplements, by region, 2013 - 2024 (USD 000)
25. Global HMO market estimates and forecast in other applications, 2013 - 2024 (Grams) (USD 000)
26. Global HMO market volume in other applications, by region, 2013 - 2024 (Grams)
27. Global HMO market revenue in other applications, by region, 2013 - 2024 (USD 000)
28. North America HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
29. North America HMO market volume, by application, 2013 - 2024 (Grams)
30. North America HMO market revenue, by application, 2013 - 2024 (USD 000)
31. U.S HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
32. U.S. HMO market volume, by application, 2013 - 2024 (Grams)
33. U.S. HMO market revenue, by application, 2013 - 2024 (USD 000)
34. Europe HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
35. Europe HMO market volume, by application, 2013 - 2024 (Grams)
36. Europe HMO market revenue, by application, 2013 - 2024 (USD 000)
37. UK HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
38. UK HMO market volume, by application, 2013 - 2024 (Grams)
39. UK HMO market revenue, by application, 2013 - 2024 (USD 000)
40. Germany HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
41. Germany HMO market volume, by application, 2013 - 2024 (Grams)
42. Germany HMO market revenue, by application, 2013 - 2024 (USD 000)
43. Asia Pacific HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
44. Asia Pacific HMO market volume, by application, 2013 - 2024 (Grams)
45. Asia Pacific HMO market revenue, by application, 2013 - 2024 (USD 000)
46. China HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
47. China HMO market volume, by application, 2013 - 2024 (Grams)
48. China HMO market revenue, by application, 2013 - 2024 (USD 000)
49. Japan HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
50. Japan HMO market volume, by application, 2013 - 2024 (Grams)
51. Japan HMO market revenue, by application, 2013 - 2024 (USD 000)
52. Latin America HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
53. Latin America HMO market volume, by application, 2013 - 2024 (Grams)
54. Latin America HMO market revenue, by application, 2013 - 2024 (USD Thousand)
55. Brazil HMO market estimates and forecast, 2013 - 2024 (Grams) (USD 000)
56. Brazil HMO market volume, by application, 2013 - 2024 (Grams)
57. Brazil HMO market revenue, by application, 2013 - 2024 (USD 000)
58. MEA HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
59. MEA HMO market volume, by application, 2013 - 2024 (Grams)
60. MEA HMO market revenue, by application, 2013 - 2024 (USD 000)
List of Figures
1. HMO market segmentation
2. Global HMO market volume and revenue, 2013 - 2024 (Grams) (USD 000)
3. HMO Market- Value chain analysis
4. HMO: Raw material outlook
5. HMO market dynamics
6. Global dairy product market, 2008 & 2012 (Million Tons)
7. Global Dietary Supplements Market, 2012 - 2020 (USD Million)
8. HMO- Key opportunities prioritized
9. HMO Porter’s analysis
10. HMO market PESTEL analysis
11. HMO market pricing trends, (USD/100mg) 2013 - 2024
12. Global HMO market volume share by application, 2015 & 2024
13. Global HMO market volume share by region, 2015 & 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report